Blink Health has also announced multiple branded drug programs, including an insulin discount program with pharmaceutical giant Eli Lilly. More than 100,000 doctors nationwide, or one in ten prescribers, have patients actively using Blink Health to save on their prescription medications. Thousands of new users sign up every day on Blink Health’s free website and mobile app, and the company now has over one million monthly active users who are accessing lower prices on the most widely prescribed generic prescriptions.
“At a time when 30 million Americans remain uninsured and 83% of American workers have an average health plan deductible of over $1,400, Blink Health is solving the nation’s drug pricing epidemic through technology.”īlink Health’s Series B financing comes on the heels of record growth since launch and accelerated recent demand. Technology has brought transparency and lower prices to almost every other category of commerce and it is about time that technology shines a light on the unfair prescription drug market,” said Joe Lonsdale, founder of 8VC. “Blink Health has quickly emerged as the first company equipped to dismantle the opacity of the prescription drug supply chain. Blink Health will use the capital to drive innovations that accelerate the company’s mission of making prescription medications affordable and transparently priced for everyone in the U.S.
8VC also led Blink Health’s $75 million Series A last year and has been a strong supporter since the company’s inception. Blink Health announced that it has raised a $90 million Series B led by 8VC, bringing its total financing to $165 million.